ClinicalTrials.gg
Drug

Metreleptin clinical trials

studies test it
23
open now
2
in phase 3
4
first study started
2001

How each study uses metreleptin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the metreleptin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
24 Feb 2014 · MYALEPT · BLA 125390 (FDA, Drugs@FDA)
European Union
30 Jul 2018 · Myalepta · EMEA/H/C/004218 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Metreleptin
17
(originally A100, recombinant-human-Methionyl-leptin
2

Brand

MyaLept
1

In one entry with another drug

Given together, or one or the other

r-metHuLeptin
4

Studies by the year they started

23 studies that test it; most in 2001 (3)

Studies that test metreleptin, by start year
YearStudies
20013
20021
20032
20062
20082
20101
20111
20121
20131
20142
20151
20181
20211
20231
20242
20251

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
15
Phase 3
4
Phase 4
2
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 9 · Other 14

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (5) · Beth Israel Deaconess Medical Center (4) · AstraZeneca (4) · University of Michigan (3) · Chiesi Farmaceutici S.p.A. (2) · Amryt Pharma (2) · Aegerion Pharmaceuticals, Inc. (1) · Elif Oral (1)

Often tested with

Tested in the same studies.

Recombinant methionyl human leptin (4) · Pramlintide (3)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 1 in phase 3

Studies that test metreleptin, phase 3 first.

Studies

Open first, then newest update. How each study uses metreleptin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 23

See all 23 studies that test metreleptin →

Codes

What other systems call metreleptin · ClinicalTrials.gg INT004283

  • MeSH (NLM) C415771metreleptinConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) TL60C27RLHMETRELEPTINConfirmed FDA, NLM, Wikidata
  • RxNorm 1491625Confirmed FDA, Wikidata
  • Wikidata Q17143468metreleptinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C170171MetreleptinOne source FDA
  • DrugBank DB09046One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.